200
Participants
Start Date
July 31, 2003
Primary Completion Date
November 30, 2011
Study Completion Date
February 29, 2012
A: Radiotherapy alone
Procedure/Surgery: A: Radiotherapy alone
B: CBDCA and Radiotherapy
Drug: B: CBDCA and Radiotherapy
Aichi Cancer Center Hospital, Nagoya
Aichi Cancer Center,Aichi Hospital, Okazaki
National Cancer Center Hospital East, Kashiwa
National Hospital Organization Shikoku Cancer Center, Natsuyama
Kyushu University Hospital, Fukuoka
Gifu Municipal Hospital, Gifu
Gunma Prefectural Cancer Center, Ōta
National Nishigunma Hospital, Shibukawa
National Hospital Organization, Dohoku National Hospital, Asahikawa
National Hospital Organization Hokkaido Cancer Center, Sapporo
Hyogo Medical Center for Adults, Akashi
Kobe City General Hospital, Kobe
Hyogo College of Medicine, Nishinomiya
Ibaraki Kenritsu Chuo Hospital & Cancer Center, Nishi-ibarakigun
Yokohama Mucipical Citizen's Hospital, Yokohama
Kanagawa Cancer Center, Yokohama
Kumamoto Regional Medical Center Hospital, Kumamoto
Tohoku University Hospital, Sendai
Niigata Cancer Center Hospital, Niigata
Okayama University Hospital, Okayama
Osaka Prefectural Medical Center for Respiratory and Allergic Disease, Habikino
Rinku General Medical Center, Izumisano
Osaka City General Hospital, Osaka
Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka
Graduate School of Medicine, Osaka City University, Osaka
Osaka General Medical Center, Osaka
Kinki University School of Medicine, Ōsaka-sayama
Kinki-Chuo Chest Medical Center, Sakai
National Hospital Organization Toneyama National Hospital, Toyonaka
Saitama Cancer Center, Kita-adachi
Sizuoka Cancer Center, Sunto-gun
Tochigi Cancer Center, Utsunomiya
National Cancer Center Hospital, Chuo-ku
Cancer Institute Hospital, Koto-ku
Toranomon Hospital, Minato-ku
International Medical Center of Japan, Shinjuku-ku
Yamagata Prefectural Central Hospital, Yamagata
Ministry of Health, Labour and Welfare, Japan
OTHER_GOV
Japan Clinical Oncology Group
OTHER